Reducing Pneumonia with LMA in Lung Wedge Resection

Launched by HAI FENG · Mar 7, 2025

Keywords

ClinConnect Summary

This clinical trial is investigating whether a specific type of anesthesia called spontaneous breathing laryngeal mask anesthesia (LMA-SBA) can help reduce the risk of pneumonia after surgery in patients undergoing a procedure known as thoracoscopic wedge resection. This is a type of lung surgery that involves removing a small wedge-shaped piece of lung tissue. The study will compare the outcomes of patients who receive this anesthesia method to those who are put under single-lung isolation mechanical ventilation, which is a more traditional approach. The researchers will also look at other factors, such as how quickly patients recover after surgery and their overall hospital stay.

To participate in this trial, individuals must be at least 18 years old and scheduled to have thoracoscopic pulmonary wedge resection surgery. They should be able to provide complete medical information before and after the procedure. However, there are certain conditions that would exclude someone from participating, such as having had prior thoracic surgery or severe heart and lung problems. The trial has been approved by the ethics committee, ensuring that it meets safety and ethical standards. If you or a loved one are considering this type of surgery, this study might provide valuable information about the best anesthesia options for recovery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ≥ 18 years ;
• • 2. Patients undergoing thoracoscopic pulmonary wedge resection ;
• • 3. General anesthesia administered intraoperatively (LMA-SBA or endotracheal intubation);
• • 4. Complete preoperative and postoperative clinical data.
• Exclusion Criteria:
• • -
• • 1)History of prior thoracic surgery; 2）Pleural adhesion or pleural effusion caused by tuberculosis or other diseases; 3)Intraoperative conversion from tubeless anesthesia to single-lung isolation-controlled ventilation; 4)Severe cardiopulmonary dysfunction (e.g., history of acute exacerbation of COPD within 1 month preoperatively, patients requiring emergency treatment, or cardiac insufficiency with limited mobility) ; 5)Preoperative neurological dysfunction or sensory abnormalities affecting pain assessment 6)Inability to cooperate with postoperative pain assessment and follow-up 7)Pregnant or breastfeeding women; 8)Patients transferred from other departments with complex comorbidities, prior treatment history, or unstable conditions .